In recent years, domestic medical glass has achieved a technological breakthrough, the overall price of borosilicon molding bottle will be further reduced. In terms of control technology, the technology of drawing tube in front kiln of borosilicate glass is basically monopolized by overseas countries. At present, most domestic enterprises mainly buy glass tubes from foreign companies, and then carry out the secondary forming process. In terms of the number of patents, from 2015 to 2021, the number of patent applications in China's borosilicate glass industry was 81.
With the progress of injection consistency evaluation, domestic demand for borosilicate glass tube replacement increased, and domestic enterprises such as Shandong Pharmaceutical Glass, ZhengChuan pharmaceutical glass and Qibin Group successively put into the layout. Since 2020, international giants have also attached great importance to the domestic market. Short and Corning have announced new plants in China.
Affected by the COVID-19 epidemic, domestic demand for borosilicate glass has been growing rapidly since the second half of 2020. With the increase of product price, the domestic borosilicate glass industry boom is obviously improved. In 2020 and 2021, the market scale of borosilicate glass in China grew rapidly, and in 2021, the market scale of borosilicate glass has grown to 1.264 billion yuan.
According to the data, the overall price of borosilicate glass has a significant decreasing trend from 2015 to 2019. From 2020 to 2021, under the influence of the COVID-19 epidemic, the demand for borosilicate glass for COVID-19 vaccine has increased significantly, and the industry supply and demand relationship is strained. The average market price has risen significantly, reaching about 15,300 yuan/ton in 2021.
The development of borosilicate glass is late, and sodium-calcium glass and low-borosilicate glass are mainly used in Chinese medicine packaging glass. At present, the domestic production of borosilicate glass manufacturers are not much, four star glass, ZhengChuan glass, Zhejiang Short, Kaisheng Junheng and so on. For a long time, China's demand for borosilicate glass is short of supply. The output of borosilicate glass in China reached 54,500 tons in 2021, with a compound annual growth rate of 32% from 2015 to 2021.
Along with the continuous development of Chinese medicine industry, marginal improvement of the demand for borosilicate glass in the field of medicine, lead to the industry product demand increase, domestic enterprise technology breakthrough, the domestication rate gradually increase, the price steadily decline, formed an obvious scale - price spiral downward ladder. Since 2020, due to the rapid growth of the demand for vaccines, the prices of products in the industry have rebounded significantly. However, with the continuous improvement of the vaccination rate, the demand impact is weakened, and the future industry product prices are expected to re-enter the downward channel.
With the promotion of the "Healthy China 2030" strategy, consistency evaluation and relevant approval system, China's requirements on the quality and safety of drug packaging are constantly improving. The specification of medicinal glass bottle is gradually in line with international standards, and the upgrade of intermediate borosilicate glass is accelerated. The demand for borosilicate glass continues to grow in domestic pharmaceutical enterprises. In December 2021, the state issued the 14th Five-Year Plan for National Drug Safety to Promote High-quality Development, which further implemented the requirements for the reform of the approval system, continued to promote the consistent evaluation of generic drugs, and improved the quality of generic drugs. It has become one of the important reform targets of the national drug and medical device approval system reform. By 2026, China's demand for borosilicate glass will rise from billions to tens of billions, and the scale of the industry will rise to tens of billions, according to a report released by Guo Jin Securities.
In the face of considerable upgrading potential space, more and more domestic enterprises to join the borosilicate medical glass industry, the whole industry presents a thriving scene. In recent years, domestic enterprises have gradually made breakthroughs in borosilicate glass tube production technology, medical borosilicate glass market will usher in a huge golden opportunity.
In the field of daily glass, with the increasing demand for high quality of life, the demand for high quality products is also expanding. High borosilicate heat-resistant glass products do not contain arsenic, lead and other harmful minerals, impact resistance, corrosion resistance and other properties have obvious advantages, widely used. With the continuous introduction of plastic restrictions around the market scale of high borosilicate glass for daily use is expanding. According to relevant reports, the average annual consumption of daily glass in China is about 10 kg /100 yuan, which is much lower than 40 kg /1000 yuan in developed countries, and the market demand has great potential.
